Authors: MADDEN S SPALDIN V PARK BK

Citation: S. Madden et al., CLINICAL PHARMACOKINETICS OF TACRINE, Clinical pharmacokinetics, 28(6), 1995, pp. 449-457

Authors: SPALDIN V MADDEN S ADAMS DA EDWARDS RJ DAVIES DS PARK BK

Citation: V. Spaldin et al., DETERMINATION OF HUMAN HEPATIC CYTOCHROME P4501A2 ACTIVITY IN-VITRO -USE OF TACRINE AS AN ISOENZYME-SPECIFIC PROBE, Drug metabolism and disposition, 23(9), 1995, pp. 929-934

Authors: MADDEN S SPALDIN V HAYES RN WOOLF TF POOL WF PARK BK

Citation: S. Madden et al., SPECIES VARIATION IN THE BIOACTIVATION OF TACRINE BY HEPATIC MICROSOMES, Xenobiotica, 25(1), 1995, pp. 103-116

Authors: PARK BK MADDEN S SPALDIN V WOOLF TF POOL WF

Citation: Bk. Park et al., TACRINE TRANSAMINITIS - POTENTIAL MECHANISMS, Alzheimer disease and associated disorders, 8, 1994, pp. 190000039-190000049

Authors: SPALDIN V MADDEN S POOL WF WOOLF TF PARK BK

Citation: V. Spaldin et al., THE EFFECT OF ENZYME-INHIBITION ON THE METABOLISM AND ACTIVATION OF TACRINE BY HUMAN LIVER-MICROSOMES, British journal of clinical pharmacology, 38(1), 1994, pp. 15-22